Dr Reddy's gets 4 observations from USFDA for Srikakulam plant
The audit of the company's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the Hyderabad-based pharma major said in a regulatory filing
No comments:
Post a Comment